Harvard Bioscience, Inc. develops, manufactures, and markets scientific instruments, systems, and lab consumables used in life science basic research, drug discovery, and clinical and environmental testing. The company offers physiology, cell, and molecular instruments, such as traditional syringe pump and peristaltic pump products, as well as a range of instruments and accessories for tissue, organ, and animal based lab research under the Harvard Apparatus, CMA Microdialysis, Panlab, Coulbourn, and Hugo Sachs brands; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation instruments that are marketed under the Biochrom, Libra, WPA, BioDrop, Hoefer, Scie-plas, and BTX brand names. It also designs, develops, and manufactures precision electrophysiology equipment specializing in patch clamp amplifiers, and manual and automated patch clamp systems under the HEKA brand; manufactures tools for electrophysiology and cell biology research consisting of cell chambers, perfusion controllers, temperature controllers, microincubation systems, and bio-sensing systems under the Warner Instruments brand; and designs and develops in vivo neural interface systems under the TBSI brand for neuroscience research, primarily in the fields of electrophysiology, psychology, neurology, and pharmacology. In addition, the company is involved in the development and manufacture of precision scientific measuring instrumentation and equipment under the Multi-Channel Systems brand; and physiologic monitoring focused on delivering preclinical products, systems, services, and solutions. Harvard Bioscience, Inc. markets its products in approximately 100 countries through sales organization, Websites, catalogs, and distributors to research scientists at universities, hospitals, government laboratories, and pharmaceutical and biotechnology companies. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
Current SymbolNASDAQ:HBIO
Previous Symbol
CUSIP41690610
Phone508-893-8999
Debt
Debt-to-Equity Ratio0.73
Current Ratio2.83
Quick Ratio1.49
Price-To-Earnings
Trailing P/E Ratio65.60
Forward P/E Ratio27.33
P/E GrowthN/A
Sales & Book Value
Annual Sales$101.88 million
Price / Sales1.20
Cash Flow$0.1583 per share
Price / Cash Flow20.72
Book Value$2.32 per share
Price / Book1.41
Profitability
EPS (Most Recent Fiscal Year)$0.05
Net Income$-860,000.00
Net Margins-4.18%
Return on Equity5.54%
Return on Assets2.89%
Miscellaneous
Employees434
Outstanding Shares37,290,000
Market Cap$126.80 million
OptionableOptionable
